64 related articles for article (PubMed ID: 27890367)
1. Evaluation of interleukin 8 +2767 A/T polymorphism in visceral leishmaniasis.
Ahmadi A; Hajilooi M; Solgi G; Abasi M; Bazmani A; Khalilian A; Matini M; Sardarian K
Asian Pac J Trop Med; 2016 Nov; 9(11):1075-1077. PubMed ID: 27890367
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interleukin-8 -251 t/a polymorphisms in visceral leishmaniasis.
Hajilooi M; Abasi M; Bazmani A; Ahmadi A; Matini M; Solgi G; Sardarian K
J Res Health Sci; 2015; 15(1):59-61. PubMed ID: 25821028
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis.
Ahmadi A; Hajilooi M; Solgi G; Abasi M; Bazmani A; Matini M; Sardarian K
Adv Biomed Res; 2015; 4():195. PubMed ID: 26605234
[TBL] [Abstract][Full Text] [Related]
4. Is the polymorphism at position -1082 of IL-10 gene associated with visceral leishmaniasis?
Hajilooi M; Ahmadi A; Lotfi P; Matini M; Jafari D; Bazmani A; Momeni M
Iran J Public Health; 2014 Aug; 43(8):1107-12. PubMed ID: 25927040
[TBL] [Abstract][Full Text] [Related]
5. Is the IL-10 -819 polymorphism associated with visceral leishmaniasis?
Hajilooi M; Sardarian K; Dadmanesh M; Matini M; Lotfi P; Bazmani A; Tabatabaiefar MA; Arababadi MK; Momeni M
Inflammation; 2013 Dec; 36(6):1513-8. PubMed ID: 23912644
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of FcγRIIIB-NA1/NA2 Polymorphism in Visceral Leishmaniasis.
Abasi M; Lotfi P; Bazmani A; Matini M; Hajilooi M
Iran Red Crescent Med J; 2014 Apr; 16(4):e12437. PubMed ID: 24910789
[TBL] [Abstract][Full Text] [Related]
7. The Cytotoxic T Lymphocyte Antigen-4 +49A/G Single Nucleotide Polymorphism Association With Visceral Leishmaniasis.
Hajilooi M; Lotfi P; Seif F; Bazmani A; Momeni M; Ravary A; Kazemi Arababadi M; Khalilian AR
Jundishapur J Microbiol; 2014 Oct; 7(10):e12143. PubMed ID: 25632324
[TBL] [Abstract][Full Text] [Related]
8. The L-selectin Phe206Leu gene polymorphism is not associated with visceral leishmaniasis.
Sardarian K; Abasi M; Solgi G; Hajilooi M
J Res Health Sci; 2014; 14(3):218-20. PubMed ID: 25209910
[TBL] [Abstract][Full Text] [Related]
9. CD 28 gene polymorphism and plasma concentration of soluble CD 28 in Iranian patients with visceral leishmaniasis.
Hashemi SH; Hajilooi M; Fallah M; Naghili B
Trop Biomed; 2010 Aug; 27(2):193-9. PubMed ID: 20962715
[TBL] [Abstract][Full Text] [Related]
10. Analysis of genetic variants in the IL4 promoter and VNTR loci in Indian patients with Visceral Leishmaniasis.
Mishra A; Jha AN; van Tong H; Singh VK; Gomes CE; Singh L; Velavan TP; Thangaraj K
Hum Immunol; 2014 Dec; 75(12):1177-81. PubMed ID: 25454624
[TBL] [Abstract][Full Text] [Related]
11. IL-18 gene polymorphism in patients with visceral leishmaniasis in East Azarbaijan, Iran.
Ahmadpour E; Bazmani A; Kohansal MH; Kazemi A; Babaloo Z
J Parasit Dis; 2016 Sep; 40(3):981-5. PubMed ID: 27605823
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of IFN-γ polymorphism in visceral leishmaniasis.
Maghsood AH; Jadideslam G; Fallah M; Bazmani A
J Res Health Sci; 2014; 14(2):136-9. PubMed ID: 24728749
[TBL] [Abstract][Full Text] [Related]
13. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
15. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
16. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
[TBL] [Abstract][Full Text] [Related]
18. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
19. The genetically determined production of the alarmin eosinophil-derived neurotoxin is reduced in visceral leishmaniasis.
Blom K; Elshafie AI; Jönsson UB; Rönnelid J; Håkansson LD; Venge P
APMIS; 2018 Jan; 126(1):85-91. PubMed ID: 29193305
[TBL] [Abstract][Full Text] [Related]
20. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
